UNITED THERAPEUTICS Corp — Director's Dealing 2021

Jul 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-07-08

Reporting Person: CAUSEY CHRISTOPHER (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-08	Restricted Stock Units	$0	A	2160	Acquired		Common Stock (2160)	Direct

Footnotes

F1: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F2: Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders

F3: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.